Milne Jill C. (CIK 1644246) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-02). Recent activity: Buy BCRX (1,262 shares), Buy BCRX (528 shares), Buy BCRX (2,582 shares), Buy BCRX (12,272 shares), Sell ATXS (4,377 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 1,262 | $11,244 |
| 2026-03-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 528 | $4,620 |
| 2026-01-27 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 2,582 | $0 |
| 2026-01-27 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 12,272 | $0 |
| 2026-01-23 | Astria Therapeutics, Inc. (ATXS) | CEO and President | Sell | 4,377 | $0 |
Source: SEC Form 4 filings · as of 2026-06-02